About us
Our projects
About cancer
Investors
News and media
Connect
Svenska

Medivir in brief
Business concept & Strategy
Leadership
- Management team
- Board of Directors
History
EFPIA Disclosure

Proprietary
- MIV-818
Projects for licensing
- Remetinostat
- MIV-711
Partnerships
- Birinapant
- Xerclear®
Publications

About cancer

Rights issue 2021
Extraordinary General Meeting 2021
Stock information
Reports
Presentations
Press releases
Calendar
Corporate Governance
General Meetings
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012

Press releases
Media bank

Connect with Medivir
Partner with Medivir

Back to archive

Events2021/04/28

Interim Report, January - March 2021

Address

Medivir AB
Box 1086
SE-141 22 Huddinge
Visit: Lunastigen 5, 2nd floor

Phone +46 (0)8 5468 31 00 Email info@medivir.com

Yilmaz Mahshid

President and CEO

yilmaz.mahshid@medivir.com

Magnus Christensen

Chief Financial Officer

magnus.christensen@medivir.com